Legal & General Group PLC Clovis Oncology, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.05 - $2.85 $28,802 - $78,178	-27,431 Reduced 98.0%	559 $1,000
Q2 2022 Aug 22, 2022	SELL	$0.63 - $2.96 $23,142 - $108,732	-36,734 Reduced 56.75%	27,990 $50,000
Q1 2022 May 16, 2022	BUY	$1.43 - $3.14 $586 - $1,287	410 Added 0.64%	64,724 $131,000
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.76 $11,140 - $19,639	4,126 Added 6.86%	64,314 $174,000
Q3 2021 Nov 15, 2021	BUY	$4.06 - $5.8 $85,052 - $121,504	20,949 Added 53.39%	60,188 $268,000
Q2 2021 Aug 12, 2021	BUY	$5.02 - $7.05 $123,080 - $172,851	24,518 Added 166.55%	39,239 $228,000
Q1 2021 May 17, 2021	BUY	$4.81 - $10.34 $1,029 - $2,212	214 Added 1.48%	14,721 $103,000
Q3 2020 Nov 13, 2020	SELL	$4.82 - $7.72 $9,524 - $15,254	-1,976 Reduced 11.99%	14,507 $85,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $37,417 - $63,721	6,576 Added 66.38%	16,483 $111,000
Q1 2020 May 14, 2020	SELL	$3.77 - $11.0 $51,430 - $150,062	-13,642 Reduced 57.93%	9,907 $63,000
Q4 2019 Feb 13, 2020	BUY	$3.0 - $16.43 $375 - $2,053	125 Added 0.53%	23,549 $246,000
Q3 2019 Nov 13, 2019	BUY	$3.93 - $15.35 $6,197 - $24,206	1,577 Added 7.22%	23,424 $92,000
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $15,269 - $30,598	1,192 Added 5.77%	21,847 $324,000
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $3,496 - $5,995	198 Added 0.97%	20,655 $513,000
Q4 2018 Feb 15, 2019	BUY	$11.63 - $32.67 $54,788 - $153,908	4,711 Added 29.92%	20,457 $368,000
Q2 2018 Aug 10, 2018	SELL	$42.06 - $62.4 $18,969 - $28,142	-451 Reduced 2.78%	15,746 $716,000
Q1 2018 May 17, 2018	SELL	$50.12 - $67.72 $156,123 - $210,947	-3,115 Reduced 16.13%	16,197 $855,000
Q4 2017 Feb 13, 2018	BUY	$57.69 - $84.58 $1.11 Million - $1.63 Million	19,312	19,312 $1.31 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account